Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-26 @ 2:34 AM
Study NCT ID:
NCT00882102
Status:
COMPLETED
Last Update Posted:
2013-09-13
First Post:
2009-04-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-15
First Submit QC Date:
None
Study First Post Date:
2009-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-06-06
Results First Submit QC Date:
None
Results First Post Date:
2013-08-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-03
Last Update Post Date:
2013-09-13
Last Update Post Date Type:
ESTIMATED